News Search Results
Jun 26, 2025, 11:35 ET HR Analytics Market Size to Surpass USD 9.89 Billion CAGR of 14.9% during 2025-2031
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jun 26, 2025, 11:30 ET Major Investment from Genome Canada to Help Advance ClarityDX Prostate Adoption Across Canada
with its ClarityDX® platform technology, announced today significant financial support from Genome Canada and Genome Alberta through the Canadian Biotechnology Innovation and Commercialization Initiative (CBIC) to accelerate the integration of ClarityDX Prostate into the standard of care for prostate cancer
More news about: Nanostics
Jun 26, 2025, 11:15 ET Embedded AI Market Size to Surpass USD 25.68 Billion by 2031|12.4% CAGR
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jun 26, 2025, 10:45 ET Data Bus Market Size to Surpass USD 32.07 Billion by 2031, Experiences Growth Owing to Rise in Demand in Aerospace and Defense Applications | The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jun 26, 2025, 10:04 ET SineuGene's SNUG01 Receives FDA Orphan Drug Designation for ALS
BEIJING, June 26, 2025 /PRNewswire/ -- SineuGene Therapeutics, a clinical-stage biotechnology company focused on gene therapies for neurological diseases, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug
More news about: SineuGene Therapeutics
Jun 26, 2025, 09:53 ET Kalorama Information Releases 2025 IVD Market Update: Innovation and Growth Surge in Clinical Chemistry, Immunoassays, and Molecular Diagnostics
exclusively focused on the healthcare industry. For over 25 years, Kalorama has delivered accurate, timely, and strategic intelligence to leaders in biotechnology, clinical diagnostics, in vitro diagnostics (IVD), pharmaceuticals, medical devices, and broader healthcare sectors. Originally launched
More news about: Kalorama Information
Jun 26, 2025, 08:30 ET STORM Therapeutics Appoints Veteran Cancer Drug Developer Dr. Eric Martin as Chief Development Officer
abstracts, and presentations. About STORM Therapeutics STORM Therapeutics is a clinical-stage biotechnology company pioneering cellular reprogramming through RNA modifications to treat disease. Its world leading understanding of RNA modifying enzymes (RME)
More news about: STORM Therapeutics
Jun 26, 2025, 08:00 ET Angel Yeast eröffnet im September den Baiyang Biotechnology Park in Yichang
Angel Yeast (SH:600298), ein weltweit führender Hersteller von Hefe, hat bekannt gegeben, dass sein Baiyang Biotechnology Park („der Park") in der Hightech-Zone von Yichang im September fertiggestellt und die Testproduktion aufgenommen werden soll. Der
More news about: Angel Yeast
Jun 26, 2025, 08:00 ET Angel Yeast Set to Open Baiyang Biotechnology Park in Yichang in September
Angel Yeast (SH:600298) a global leader in yeast manufacturing, has announced that its Baiyang Biotechnology Park ("the Park") located in the Yichang High-Tech Zone will complete construction and commence trial production in September. The Park
More news about: Angel Yeast
Jun 26, 2025, 08:00 ET Angel Yeast Set to Open Baiyang Biotechnology Park in Yichang in September
Angel Yeast (SH:600298) a global leader in yeast manufacturing, has announced that its Baiyang Biotechnology Park ("the Park") located in the Yichang High-Tech Zone will complete construction and commence trial production in September. The Park is
More news about: Angel Yeast
Jun 26, 2025, 07:30 ET Cellarity Initiates Phase 1 Clinical Study of CLY-124, a First-in-Class Globin-Switching Oral Medicine for the Treatment of Sickle Cell Disease
SOMERVILLE, Mass., June 26, 2025 /PRNewswire/ -- Cellarity, a biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced that the first subject has been
More news about: Cellarity
Jun 26, 2025, 07:00 ET HotSpot Therapeutics to Present Preclinical Data from Small Molecule CBM Signalosome Inhibitor Program at ESMO Gastrointestinal Cancers Congress 2025
BOSTON, June 26, 2025 /PRNewswire/ -- HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, small molecule allosteric therapies targeting Smart Allostery platform-identified regulatory
More news about: HotSpot Therapeutics
Jun 26, 2025, 07:00 ET Nanoscope Therapeutics Propels Patient-Centered Innovation in Inherited Retinal Diseases with New Visionary Advisory Committee
Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel gene-agnostic therapies for patients suffering severe vision loss from retinal degenerative
More news about: Nanoscope Therapeutics
Jun 26, 2025, 07:00 ET Peptone Hosts In-Person Advisory Meeting With Leading Experts in Oncology, Drug Development and Medicinal Chemistry to Advance Small Molecule IDP-Targeted Treatment Solutions
David Blakey, Peptone Advisor; Chief Scientific Officer, FasT BiopharmaAbout PeptonePeptone is a biotechnology company developing novel first-in-class small molecule therapeutics targeting intrinsically disordered proteins (IDPs) to treat diseases through
More news about: Peptone
Jun 25, 2025, 16:45 ET Kodiak Sciences to Present KSI-101 Highlights at 2025 Congress of the International Ocular Inflammation Society
studies (PEAK and PINNACLE) in MESI. Kodiak Sciences Inc. Kodiak Sciences (Nasdaq: KOD) is a precommercial retina focused biotechnology company committed to researching, developing, and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases. We
More news about: Kodiak Sciences Inc.
Jun 25, 2025, 16:15 ET HotSpot Therapeutics Presents Preclinical Data from Small Molecule IRF5 Program at FOCIS 2025
BOSTON, June 25, 2025 /PRNewswire/ -- HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, small molecule allosteric therapies targeting Smart Allostery platform-identified regulatory
More news about: HotSpot Therapeutics
Jun 25, 2025, 13:00 ET Genective Poised for Commercial Success After Pipeline Delivered Breakthrough Insect Control Results
a strong foundation for commercialization, Genective is fulfilling its vision of being a globally impactful contributor to agriculture through biotechnology for corn, soy, and cotton. About GenectiveGenective is a 100% subsidiary of Groupe Limagrain, a French Agri-food
More news about: Genective
Jun 25, 2025, 11:30 ET SLC NAND Flash Memory Market Size to Surpass USD 16.40 Billion by 2031 With CAGR 5.3% | The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jun 25, 2025, 11:00 ET High Heat Bearing Market Size worth $10.71 billion by 2031 | 6.8% CAGR
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jun 25, 2025, 10:36 ET JOSEPH HERNANDEZ, INDEPENDENT ENTREPRENEUR, FILES 15,000 PETITION SIGNATURES AND LAUNCHES MAYORAL CAMPAIGN TO RESTORE SAFETY AND BRING BACK COMMON SENSE TO NYC
States at age seven after his family fled communist rule. Raised by working-class parents, he went on to build a nationally recognized career in biotechnology, founding multiple healthcare companies, raising over $1 billion in private and public capital, and delivering breakthrough
More news about: Hernandez for NYC
Jun 25, 2025, 10:30 ET Home Automation Market Size to Grow USD 135.13 Billion by 2031, at a CAGR of 10.8% | The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jun 25, 2025, 10:15 ET Rosalind Franklin University Helix 51 Company UP Oncolytics Secures Wisconsin Economic Development Matching Grant to Advance Oncolytic Virus Therapy for Brain Cancer
Ill., June 25, 2025 /PRNewswire/ -- UP Oncolytics, a neuro-oncology biotechnology company based in Milwaukee and a spin-out of the Advocate Aurora Research Institute, has received a $75,000
More news about: Rosalind Franklin University of Medicine and Science
Jun 25, 2025, 09:00 ET PM360 Announces 2025 Lifetime Achievement Award winner
leadership in the biotechnology sector. "Not only is he a brilliant scientist and entrepreneur, he is [also] a very good human being." Dr. Barer is best known for his pivotal role at Celgene Corporation, where he served as Chairman and CEO. He was also the founder of the biotechnology group at Celanese
More news about: PM360
Jun 25, 2025, 08:33 ET RayBiotech and Venebio Group Enter Strategic Collaboration to Accelerate Drug and Diagnostics Development
research. About Venebio Group, LLCVenebio Group is a scientific consultancy that provides strategic support for pharmaceutical, biotechnology, and medical device companies. Their expertise spans regulatory affairs, clinical trial and observational study design, data science and epidemiology,
More news about: RayBiotech
Jun 25, 2025, 08:00 ET InSysBio to announce extension of collaboration with discoveric bio alpha
the world's pioneers of Quantitative Systems Pharmacology (QSP) modeling, announces the extension of collaboration with discoveric bio alpha, a biotechnology company taking next generation antibody technologies into Alzheimer's Disease.
More news about: InSysBio